XILIO THERAPEUTICS INC

Ticker: XLO CUSIP: 98422T100 Class: COM

Atlas Venture Life Science Advisors, LLC's Holding History (CIK: 0001917529)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 992,912 Value ($000) $1,072 Avg Close $0.69 Range $0.50 - $1.93
Q4 2023
Shares 2,759,344 Value ($000) $1,518 Avg Close $1.41 Range $0.49 - $2.89
Q3 2023
Shares 2,759,344 Value ($000) $5,822 Avg Close $2.66 Range $1.98 - $2.94
Q2 2023
Shares 2,759,344 Value ($000) $7,229 Avg Close $3.04 Range $2.26 - $3.67
Q1 2023
Shares 2,759,344 Value ($000) $8,747 Avg Close $3.14 Range $2.49 - $4.92
Q4 2022
Shares 2,759,344 Value ($000) $7,423 Avg Close $2.41 Range $1.95 - $3.14
Q3 2022
Shares 2,759,344 Value ($000) $8,030 Avg Close $2.77 Range $2.01 - $4.71
Q2 2022
Shares 2,759,344 Value ($000) $8,057 Avg Close $3.78 Range $2.04 - $8.00
Q1 2022
Shares 2,759,344 Value ($000) $19,509 Avg Close $11.30 Range $6.59 - $16.34
Q4 2021
Shares 2,759,344 Value ($000) $44,150 Avg Close $17.03 Range $8.53 - $27.95